Pseudoxanthoma Elasticum Clinical Trial
Official title:
Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
This study aims to systematically assess the retest reliability and ability to detect a change of new visual function tests and ophthalmological imaging methods for observing the natural course of pseudoxanthoma elasticum (PXE).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02537054 -
Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
|
Phase 2 | |
Completed |
NCT05569252 -
A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
|
Phase 2 | |
Completed |
NCT03070860 -
What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum
|
N/A | |
Completed |
NCT01446393 -
Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE)
|
N/A | |
Completed |
NCT00470977 -
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03758534 -
Natural History of GACI With or Without ARHR2 or PXE
|
||
Recruiting |
NCT05734196 -
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
|
Phase 1 | |
Not yet recruiting |
NCT06462547 -
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
|
Phase 2 | |
Recruiting |
NCT01446380 -
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
|
N/A | |
Recruiting |
NCT03813550 -
Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)
|
N/A | |
Not yet recruiting |
NCT03364504 -
Biological Collection of Kidney Cells
|
N/A | |
Active, not recruiting |
NCT02108392 -
Characterization of Pseudoxanthoma Elasticum
|
||
Recruiting |
NCT01731080 -
Arterial Wall Calcium Load in Pseudoxanthoma Elasticum
|
N/A | |
Completed |
NCT00555113 -
Evolution of Visual Impairment During Pseudoxanthoma Elasticum
|
N/A | |
Completed |
NCT00341419 -
Genetic Analysis of Patients With Pseudoxanthoma Elasticum
|
||
Withdrawn |
NCT04441671 -
Oral Pyrophosphate Absorption in PXE Disease
|
Phase 2 | |
Recruiting |
NCT04868578 -
PPI Supplementation to Fight ECtopIc Calcification in PXE
|
N/A | |
Completed |
NCT05025722 -
Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
|
||
Completed |
NCT01525875 -
Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
|
Phase 2 | |
Completed |
NCT05246189 -
Employment of Patients With Pseudoxanthoma Elasticum
|